Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
12.57
-0.07 (-0.55%)
May 30, 2025, 4:00 PM - Market closed
Avanos Medical Market Cap
Avanos Medical has a market cap or net worth of $581.29 million as of May 30, 2025. Its market cap has decreased by -36.97% in one year.
Market Cap
581.29M
Enterprise Value
625.19M
1-Year Change
-36.97%
Ranking
Category
Stock Price
$12.57
Market Cap Chart
Since October 21, 2014, Avanos Medical's market cap has decreased from $1.91B to $581.29M, a decrease of -69.53%. That is a compound annual growth rate of -10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 581.30M | -20.54% |
| Dec 31, 2024 | 731.60M | -29.74% |
| Dec 29, 2023 | 1.04B | -17.24% |
| Dec 30, 2022 | 1.26B | -24.69% |
| Dec 31, 2021 | 1.67B | -23.88% |
| Dec 31, 2020 | 2.19B | 35.87% |
| Dec 31, 2019 | 1.62B | -23.97% |
| Dec 31, 2018 | 2.12B | -1.78% |
| Dec 29, 2017 | 2.16B | 25.31% |
| Dec 30, 2016 | 1.73B | 10.83% |
| Dec 31, 2015 | 1.56B | -26.40% |
| Dec 31, 2014 | 2.12B | 10.90% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 661.41B |
| Johnson & Johnson | 372.41B |
| AbbVie | 325.99B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.38B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 224.00B |
| Novartis AG | 219.70B |